Carbidopa Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 25 mg

Reference Brands: Generic formulations marketed under different names

Category: Neurology

Product Description:

Carbidopa, marketed under the brand name Lodosyn, is a medication primarily used in the management of Parkinson’s disease. It works by inhibiting the enzyme aromatic L-amino-acid decarboxylase (DOPA decarboxylase or DDC) in the peripheral tissues, which prevents the premature conversion of Levodopa to dopamine outside the brain. This inhibition allows a greater proportion of administered Levodopa to cross the blood–brain barrier and exert its therapeutic effect in the central nervous system, effectively improving the control of Parkinson’s disease symptoms such as tremor, rigidity, and bradykinesia.

By selectively targeting peripheral DDC, Carbidopa enhances the bioavailability of Levodopa while minimizing side effects related to peripheral dopamine accumulation, including nausea, vomiting, and cardiovascular issues. The medication is available in oral tablet form and is often used in combination with Levodopa for optimal therapeutic outcomes. Carbidopa’s ability to preserve Levodopa for central nervous system activity makes it an essential component in Parkinson’s disease therapy, supporting both motor function and quality of life for patients. Its predictable pharmacologic profile and compatibility with Levodopa make it a preferred agent in long-term Parkinson’s disease management.